Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents

European Journal of Pharmacology

Volumn 321, Issue 3, 1997, Pages 273-278

  Imanishi, Taiichiro ^a   Sawa, Aiko ^a   Ichimaru, Yasuyuki ^a   Miyashiro, Mio ^a   Kato, Shinsuke ^a   Yamamoto, Tsuneyuki ^b   Ueki, Showa ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

3 Panel runway; cAMP; Learning; Memory; Passive avoidance; Rolipram

Indexed keywords

BUCLADESINE; CYCLIC AMP; CYCLOHEXIMIDE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SCOPOLAMINE;

AMNESIA; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; SHOCK;

ANIMALS; AVOIDANCE LEARNING; BRAIN ISCHEMIA; BUCLADESINE; CYCLIC AMP; ELECTROSHOCK; LEARNING; MALE; MEMORY; MICE; MOTOR ACTIVITY; PHOSPHODIESTERASE INHIBITORS; PYRROLIDINONES; RATS; RATS, WISTAR; ROLIPRAM; SCOPOLAMINE;

EID: 0031048406     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00969-7     Document Type: Article

References (35)

1. Ando, S., H. Kametani, H. Osada, M. Iwamoto and N. Kimura, 1987, Delayed memory dysfunction by transient hypoxia, and its prevention with forskolin, Brain Res. 405, 371.
2. Beavo, J.A., 1988, Multiple isozymes of cyclic nucleotide phosphodiesterase, in: Advances in second messenger and phosphoprotein research 22, ed. P. Greengard and G.A. Robinson (Raven Press, New York, NY) p. 1.
3. Chutae, D.L., J.W. Villiger and N.F. Kirton, 1981, Testing cyclic AMP mediation of memory: reversal of α-methyl-p-tyrosine-induced amnesia, Psychopharmacology 74, 129.
4. Danilova, R., E. Gurevich and Z. Storozheva, 1985, Effect of 8-Br-cAMP on the formation of conditioned reflex behavior in the white rat, Zh. Vyssh. Nerv. Deiat. 35, 267.
5. De Noble, V., S.J. Repetti, L.W. Gelpke, L.M. Wood and K.L. Keim, 1986, Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats, Pharmacol. Biochem. Behav. 24, 1123.
6. Donaldson, J., A.M. Brown and S.J. Hill, 1988, Influence of rolipram on the cyclic 3′,5′-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex, Biochem. Pharmacol. 37, 715.
7. Eckmann, F., K. Fichte, U. Meya and M. Sastre-y-Hernandez, 1988, Rolipram in major depression: results of a double blind comparative study with amitriptyline, Curr. Ther. Res. 43, 291.
8. Frey, U., Y. Huang and E. Kandel, 1993, Effects of cAMP stimulate a late stage of LTP in hippocampal CAl neurons, Science 260, 1661.
9. Fu, W.M., 1993, Potentiation of acetylcholine responses in Xenopus embryonic muscle cells by dibutyryl cAMP, Pflügers Arch. 425, 439.
10. Furuya, Y., T. Yamamoto, S. Yatsugi and S. Ueki, 1988, A new method for studying working memory by using the three-panel runway apparatus in rats, Jpn. J. Pharmacol. 46, 183.
11. Goto, M., N. Demura and T. Sakaguchi, 1987, Effects of propentofylline on disorder of learning and memory in rodents, Jpn. J. Pharmacol. 45, 373.
12. Hudlicka, O., J. Komarek and A.J.A. Wright, 1981, The effect of an xanthine derivative, 1-(5-oxohexyl)-3-methyl-7-propylxanthine (HWA 285), on heart performance and regional blood flow in dogs and rabbits, Br. J. Pharmacol. 72, 723.
13. Kogure, K., P. Scheinberg and A. Matsumoto, 1974, Catecholamines in experimental brain ischemia, Arch. Neurol. 32, 21.
14. Lemmer, B., T. Ohm and J. Bohl, 1989, Reduced basal and stimulated adenylate cyclase activity in post-mortem hippocampus of Alzheimer patients, Naunyn-Schmiedeberg's Arch. Pharmacol. 339, R108.
15. Nakamura, M., C. Nishio, T. Nonomura and H. Hatanaka, 1994, High potassium and cyclic AMP analog promote neuronal survival of basal forebrain cholinergic neurons in culture from postnatal 2-week-old rats, Brain Res. Dev. Brain Res. 81, 218.
16. Newman, M., H. Solomon and B. Lerer, 1986, Electroconvulsive shock and cyclic AMP signal transduction: effects distal to the receptor, J. Neurochem. 46, 1667.
17. Nguyen, P., T. Abel and E. Kandel, 1994, Requirement of a critical period of transcription for induction of a late phase of LTP, Science 265, 1104.
18. Nicholson, C.D. and D. Angersbach, 1986, Denbufylline (BRL 30892) - a novel drug to alleviate the consequences of cerebral ischaemia, in: Pharmacology of Cerebral Ischemia, ed. J. Krieglstein (Elsevier, Amsterdam) p. 371.
19. Nicholson, C.D., J.J. Jukna, R. Wilke and D. Angersbach, 1989, Effect of denbufylline in passive avoidance trials in gerbils, following transient forebrain ischemia, and in mice, Drug Dev. Res. 14, 349.
20. O'Connolly, M.O., M.-E.R. Mayer, D. Woif, M. Brett and W.H. Greb, 1986, Efficacy and tolerance of denbufylline (BRL 30892) in patients with cerebrovascular disease - an investigational study with a new agent, in: Pharmacology of Cerebral Ischemia, ed. J. Krieglstein (Elsevier, Amsterdam) p. 440.
21. Ohtomo, E., M. Hayashi, H. Makishita, A. Tamura, R. Hanakago, K. Kino, M. Murata, G. Hirose, M. Matsubara, T. Sawada and J. Kawamura, 1986, Clinical open study of HWA 285 in cerebrovascular disorders-with special regard to long-term administered patients, J. Pharmacol. Ther. 14, 2481.
22. Przegalinski, E. and K. Bigajska, 1983, Antidepressant properties of some phosphodiesterase inhibitors, Pol. J. Pharmacol. Pharm. 25, 233.
23. Pulsinelli, W.A. and J.B. Brierley, 1979, A new method of bilateral hemispheric ischemia in the unanesthesized rat, Stroke 10, 253.
24. Randt, C.T., M.E. Judge, K.A. Bonnet and D. Quartermain, 1982, Brain cyclic AMP and memory in mice, Pharmacol. Biochem. Behav. 17, 677.
25. Schneider, H.H., 1984, Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation, Biochem. Pharmacol. 33, 1690.
26. Schoffelmeer, A.N.M., G. Wardeh and A.H. Mulder, 1985, Cyclic AMP facilitates the electrically evoked release of radiorabelled noradrenaline, dopamine and 5-hydroxytryptamine from rat brain slices, Naunyn-Schmiedeberg's Arch. Pharmacol. 330, 74.
27. Subhan, Z. and I. Hindmarch, 1985, Psychopharmacological effects of vinpocetine in normal healthy volunteers, Eur. J. Clin. Pharmacol. 28, 567.
28. 2-dibutyryl-3′,5′-cyclic AMP (dbcAMP), Jpn. J. Pharmacol. 24, 51.
29. Wachtel, H., 1983, Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors, Neuropharmacology 22, 267.
30. Wachtel, H. and P-.A. Loschmann, 1986, Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram, Psychopharmacology 90, 430.
31. Wachtel, H. and H.H. Schneider, 1986, Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond post synaptic monoamine receptors, Neuropharmacology 25, 1119.
32. Weiner, M. and J.W. Olson, 1973, Behavioural effects of dibutyryl cyclic AMP in mice, Life Sci. 12, 345.
33. Yamamoto, T., S. Yatsugi, M. Ohno, Y. Furuya, I. Kitajima and S. Ueki, 1990, Minaprine improves impairments of working memory induced by scopolamine and cerebral ischemia in rats, Psychopharmacology 100, 316.
34. Yamamoto, T., M. Ohno, I. Kitajima, S. Yatsugi and S. Ueki, 1993, Ameliorative effects of the central active cholinesterase inhibitor, NIK-247, on impairment of working memory in rats, Physiol. Behav. 53, 5.
35. Yatsugi, S., T. Yamamoto, M. Ohno and S. Ueki, 1989, Effect of S-adenosyl-L-methionine on impairment of working memory induced in rat by cerebral ischemia and scopolamine, Eur. J. Pharmacol. 166, 231.